The agrochemical sector, which makes seeds and pesticides, has come alive with mega-deals. Last week, German chemicals giant Bayer, which specialises in herbicides, launched a $62bn bid for US-based Monsanto. This follows a $130bn merger last year between Dow Chemical and DuPont, two American chemical giants, while ChemChina has launched a $43bn bid for Switzerland's Syngenta.
Still, obstacles to this deal are manyfold. Monsanto has rebuffed Bayer's bid, which already looks pricey. Even if Bayer offers a higher price, US regulators could halt a deal: they intervened in 2007 when stopping Monsanto from buying a rival cotton seed producer, on the grounds that the combination would be too big, squeezing US farmers. So investors in Monsanto shouldn't bet on a higher offer.
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Take some profits.
-
Financial education: how to teach children about moneyFinancial education was added to the national curriculum more than a decade ago, but it doesn’t seem to have done much good. It’s time to take back control
-
Investing in Taiwan: profit from the rise of Asia’s Silicon ValleyTaiwan has become a technology manufacturing powerhouse. Smart investors should buy in now, says Matthew Partridge
